Found 33 matching trials
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
PHASE3Primary objective was to assess the effectiveness evaluated by the time to ...
Location
Investigational Site Number 056003
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
PHASE1Triple negative breast cancer (TNBC) represents about 15% of breast cancers...
To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis
PHASE4Primary Objective:
To describe the safety of teriflunomide in patients wit...
Location
Investigational Site Number :024
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
PHASE3The primary objective of the study was to assess the effect of two doses of...
Location
Sanofi-Aventis Investigational Site Number 840041
Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome
PHASE3Multiple sclerosis (MS) is a common cause of severe neurological disability...
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
PHASE3Primary Objective:
To assess efficacy of daily SAR442168 compared to a dai...
Location
University of Alabama MS Center-Site Number:8400013
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)
PHASE3This study determines the Annualized Relapse Rate (ARR) in participants wit...
Location
TG Therapeutics RMS Investigational Trial site
Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
PHASE2The primary objective of this study was to determine the safety and efficac...
Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
PHASE1Primary Objective:
\- To determine the effect of severe renal impairment o...
Location
Sanofi-Aventis Administrative Office
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
PHASE4Primary Objective:
To describe efficacy, tolerability and convenience of t...
Location
Investigational Site Number 840077